Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of SOR-C13 in Patients With Advanced Solid Tumors

NCT03784677 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT03784677
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03784677 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of SOR-C13 in Patients With Advanced Solid Tumors
Lead sponsor
M.D. Anderson Cancer Center
Phase
Phase 1
Overall status
Completed
Start date
July 29, 2019
Completion date
June 20, 2023
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced malignant solid neoplasm, refractory malignant solid neoplasm, refractory ovarian carcinoma, refractory pancreatic carcinoma, stage ii pancreatic cancer ajcc v8, stage iia pancreatic cancer ajcc v8, stage iib pancreatic cancer ajcc v8, stage iii ovarian cancer ajcc v8, stage iii pancreatic cancer ajcc v8, stage iii prostate cancer ajcc v8, stage iiia ovarian cancer ajcc v8, stage iiia prostate cancer ajcc v8, stage iiib ovarian cancer ajcc v8, stage iiib prostate cancer ajcc v8, stage iiic ovarian cancer ajcc v8, stage iiic prostate cancer ajcc v8, stage iv ovarian cancer ajcc v8, stage iv pancreatic cancer ajcc v8, stage iv prostate cancer ajcc v8, stage iva ovarian cancer ajcc v8, stage iva prostate cancer ajcc v8, stage ivb ovarian cancer ajcc v8, stage ivb prostate cancer ajcc v8